X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Liver Diseases TherapeuticsCompanies

This report lists the top Liver Diseases Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Liver Diseases Therapeutics industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Liver Disease Drugs Research Liver Cirrhosis Treatment Industry Companies

Liver Diseases TherapeuticsTop Companies

  1. Abbott Laboratories

  2. Gilead Sciences

  3. Novartis

  4. Sanofi

  5. Astellas Pharma

*Disclaimer: Top companies sorted in no particular order

Liver Diseases Therapeutics Market Major Players

Liver Diseases TherapeuticsMarket Concentration

Liver Diseases Therapeutics Market Concentration

Liver Diseases TherapeuticsCompany List

  • Abbott Laboratories

  • Astellas Pharma Inc.

  • Bristol-Myers Squibb Company

  • Gilead Sciences

  • GlaxoSmithKline PLC

  • F. Hoffmann-La Roche Ltd.

  • Merck & Co. Inc.

  • Novartis AG

  • Sanofi AG

  • AbbVie Inc.

  • Endo International PLC

  • Pfizer Inc.

  • Takeda Pharmaceutical

  • Alnylam Pharmaceuticals Inc.

  • Provectus Biopharmaceuticals Inc.


Specific to Liver Diseases Therapeutics Market
Need More Details On Market Players And Competitors?
Download PDF

Liver Cirrhosis Treatment Market Report Snapshots

Liver Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)